Sur-5 Protein: A Potential Drug Target for Sleep Disorders (G65985)

Target Name: AACS

NCBI ID: G65985

AACS

Sur-5 Protein: A Potential Drug Target for Sleep Disorders

The article discusses the Homolog of C. elegans Supressor of Ras 5 (sur-5) protein, which is a key regulator of the Rapid Eye Movement (REM) sleep cycle in Caenorhabditis elegans. The protein is a potential drug target or biomarker for the treatment of sleep disorders and other neurological conditions.

The C. elegans model is widely used in research to study the effects of drugs on behavior and neural circuitry. The nematode worm Caenorhabditis elegans is well-known for its simple nervous system, which consists of a single layer of neurons. The study of C. elegans has provided valuable insights into the mechanisms of neural function and the effects of drugs on behavior.

The Homolog of C. elegans Supressor of Ras 5 (sur-5) is a key regulator of the REM sleep cycle in Caenorhabditis elegans. The REM sleep cycle is a critical aspect of sleep, as it is associated with the consolidation of memories and the transfer of learning to long-term memory. The sur-5 protein plays a crucial role in regulating the duration and frequency of REM sleep episodes.

The sur-5 protein is a member of the RAS/MAPK pathway, which is a well-established signaling pathway that regulates a variety of cellular processes, including stress response, growth, and differentiation. The RAS/MAPK pathway is activated in response to changes in the environment, including changes in light intensity, temperature, and nutrient availability.

The sur-5 protein is expressed in the worm's hypothalamus, which is the central command center of its nervous system. It is involved in the regulation of sleep-wake cycles, as well as other aspects of behavioral behavior. Sur-5 has been shown to interact with a variety of other proteins, including the heat shock protein (Hsp)16.2, which is involved in stress response and DNA damage repair.

The potential drug target status of the sur-5 protein is an attractive feature, as it suggests that drugs that target this protein may have therapeutic benefits for a variety of neurological conditions. Sleep disorders, such as insomnia and sleep apnea, are a common condition that affects millions of people worldwide. The failure of current treatments to effectively treat these disorders suggests the need for new and innovative approaches to drug development.

In addition to its potential therapeutic applications, the sur-5 protein is also a valuable research tool for the study of neuroscience. The worm's simple nervous system provides a relatively uncomplicated model for the study of neural circuitry and the effects of drugs on behavior. The analysis of behavior and neural circuitry data from Caenorhabditis elegans can provide valuable insights into the mechanisms of neural function and the effects of drugs on behavior.

In conclusion, the Homolog of C. elegans Supressor of Ras 5 (sur-5) protein is a key regulator of the REM sleep cycle in Caenorhabditis elegans. Its potential drug target status and its involvement in the RAS/MAPK pathway make it an attractive target for the development of new therapies for sleep disorders and other neurological conditions. Further research is needed to fully understand the mechanisms of sur-5's function and its potential as a therapeutic target.

Protein Name: Acetoacetyl-CoA Synthetase

Functions: Converts acetoacetate to acetoacetyl-CoA in the cytosol (By similarity). Ketone body-utilizing enzyme, responsible for the synthesis of cholesterol and fatty acids (By similarity)

The "AACS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about AACS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets